from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1940/ribA1

LFCtreatmentdescriptionclass of inhibitor

-0.311

Amikacinug/mL Amikacintranslation

-1.140

Cap5-10ug/mL Capreomycintranslation

0.355

Rox10-50 ug/mL Roxithromycintranslation

-0.631

SM2-5 ug/mL Streptomycintranslation

1.046

Tet5-10 ug/mL Tetracyclinetranslation

-0.111

Rif0.2-5ug/mL Rifampicintranscription

0.398

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.103

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.781

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.892

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.807

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.643

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.312

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.859

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.214

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.491

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.902

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.225

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.092

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.264

KCN5-20 ug/mL Potassium cyaniderespiration

1.806

NaN30.2-2 mM Sodium aziderespiration

-0.670

Nigericin50 uM Nigericinrespiration

0.089

TRC10-150 ug/mL Triclosanrespiration

-0.461

TRZ10-25 ug/mL Thioridazinerespiration

0.674

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.634

menadione6-10 ug/mL Menadionerespiration

0.108

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.466

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.041

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.134

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.022

NRP_1Non-replicating persistence stage 1dosRassociated

-0.508

Amp0.2mg/mL AmpicillincellWall

-0.443

Cephalexin20-100 ug/mL CephalexincellWall

0.706

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.527

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.375

EMB10-20 ug/mL EthambutolcellWall

-0.483

Eta12-40 ug/mL EthionamidecellWall

-0.290

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.132

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.627

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.043

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.944

BZA0.12 mg/mL BenzamidearomaticAmides

-0.603

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.582

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.228

H2O24 mM hydrogen peroxideDNAdamaging

-0.249

Levo10 ug/mL LevofloxacinDNAdamaging

-0.091

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.668

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.490

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.593

UVUV-irradiationDNAdamaging

0.431

ARP41-4 ug/mL Antitubercular compound ARP4?

0.085

Antimycin12.5-50 ug/mL Antimycin A?

-0.325

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.305

PA_110-50 ug/mL Antitubercular compound PA-1?

0.187

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.759

PA8240.2-2 ug/mL PA-824?

1.345

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.281

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.518

Verapamil50 uM Verapamil?

-0.174

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.293

methoxatin10-20 ug/mL Methoxatin?